Blue Ocean Capital Group (“BOCG”) is a life science focused venture capital investment firm and has carried out investments in the innovative biotech hubs of Greater China, USA and Northern Europe.

BOCG is committed to driving the innovation and transformation of biotechnology to startups, empowering the development of portfolio companies, leveraging its tremendous experience, extensive industrial network, and scientific research resources globally. Since its founding in late 2015, BOCG has invested in various innovative biotech and medical device companies with US$300+ million in cumulative capital commitments.

BOCG’s team is comprised of industry elites from Sanofi, Philips, Pfizer and AstraZeneka and seasoned professionals from scientific research, clinical and investment backgrounds, which equip the team with comprehensive capabilities from investment to value creation in the life science ecosystem. Mr. Frank Yang, the founder of BOCG, has 25 years’ experience in PE/VC industry with proven records of billion-dollar investment. Prior to founding BOCG, Mr. Yang served as managing director and Responsible Officer at CCBI Asset Management from 2010 to 2016, responsible for principal investments and a healthcare-focused RMB 3 billion fund (US$400 million); prior to that, he worked at leading investment firm Texas Pacific Group (TPG) and PPF with senior management positions.

BOCG is committed to fueling breakthroughs across biotechnology, including small molecule drugs, antibodies, gene editing and cell therapy, nucleic acid drugs and organoid; high-end innovative medical devices, and healthTech. BOCG has a proven track record of innovative healthcare investments including Innorna, Signet Therapeutics, Koka Lifesicences, Boan Biotech, Ribo Life Science, and R Plus Health. BOCG has extensive experience in cross-border M&A and capital markets, including the signature investments of US$250 million in Global Cord Blood Corporation, which achieved a successful exit with hundreds of millions dollar profit and attractive return.

BOCG is more than an investment firm, but also a dynamic platform to promote ESG and fuel the most innovative companies. As a signatory to the United Nations-supported Principles for Responsible Investment ("UN PRI"), BOCG is devoted to responsible investment and empowers sustainable development of the portfolio companies.